Condition category
Mental and Behavioural Disorders
Date applied
Date assigned
Last edited
Retrospectively registered
Overall trial status
Recruitment status
No longer recruiting
Publication status

Plain English Summary

Background and study aims
Autism Spectrum Disorder (ASD) is the name for a group of disorders that affect the way that a person communicates and relates to others. It is a spectrum condition the level of disability is spread across a wide range, from almost unnoticeable to completely debilitating. In general however, the difficulties sufferers experience tend to fall into social communication (speech and body language), social interaction (recognising and expressing emotions) and social imagination (being able to understand and predict other people’s behaviour). ASD is common, affecting around 1 in every 68 children in North America. Current treatment strategies for autism often rely on addressing behavior and target mostly very young infants and toddlers. There is an urgent need to develop effective, easy to administer interventions for school age children with autism. Music therapy offers such an approach. Studies have shown that musical activities activate large areas of the brain and brain scan (neuroimaging) studies in children with ASD have shown intact or even enhanced processing of music. Given the motivational value of music and the effect it can have on the brain and behavior, it is important to conduct further studies for establishing the effectiveness of music in ASD. The aim of this study is to investigate whether musical based therapy can better improve social and communication skills in children with ASD than non-musical based therapy.

Who can participate?
Children aged 6-12 years with ASD.

What does the study involve?
Participants are randomly allocated to one of two groups. Those in the first group take part in the musical programme for 12 weeks. This involves using various musical instruments and songs to engage the children and try to improve social and communication skills. Those in the second group take part in a non-musical programme for 12 weeks which involves using toys, books and other non-musical accessories to try to improve social and communication skills. All sessions (for both groups) take place every week and last for around 45 minutes. They are one-to-one and are led by an experienced music therapist. At the start of the study and then again after 12 weeks, participants in both groups complete a number of questionnaires to test their social and communication skills. In addition, at the same times, participants have an MRI scan of their brains to find out if the therapy has caused new brain connections to form.

What are the possible benefits and risks of participating?
There are no notable benefits or risks involved with participating in this study.

Where is the study run from?
1. University of Montreal (Canada)
2. McGill University (Canada)
3. Westmount Music Therapy (Canada)
4. Montreal Neurological Institute (Canada)

When is the study starting and how long is it expected to run for?
March 2013 to May 2014

Who is funding the study?
Quebec Bioimaging Network (Canada)

Who is the main contact?
Dr Megha Sharda

Trial website

Contact information



Primary contact

Dr Megha Sharda


Contact details

University of Montreal
International Laboratory for Brain
Music and Sound Research (BRAMS)
1430 Mont-Royal Boulevard
H2V 2J2
+1 514 343 6111

Additional identifiers

EudraCT number number

Protocol/serial number


Study information

Scientific title

A randomized control trial of a music-based intervention for children with autism - brain and behavioural mechanisms of efficacy


Study hypothesis

Children with autism spectrum disorder (ASD) receiving the music intervention will have larger gains in terms of social and communication skills compared to those receiving a non-music intervention. These gains will be reflected in differences in brain connectivity in fronto-temporal regions.

Ethics approval

McGill University Health Centre (MUHC) and the Montreal Neurological Institute and Hospital (MNI/H), 19/02/2016, ref: NEU-10-030

Study design

Single-centre single-blind randomized controlled trial

Primary study design


Secondary study design

Randomised controlled trial

Trial setting


Trial type


Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet.


Autism Spectrum Disorder


Participants are randomized to one of two groups. The first 20 participants will be randomized using simple coin toss. Subsequent randomization will be conducted using the covariate adaptive randomization method to ensure balance of demographic factors such as age, sex and language ability between the two groups. MinimPy software will be used to conduct this randomization by one member of the team not involved in experimental testing. All other experimenters will be blind at all times to the assignment of participants.

Intervention group: Participants take part in the music-based intervention, which involves attending individual 45 minute sessions once a week for 12 weeks. The sessions involve use of song, rhythmic cues and instruments to target socio-communicative, emotional and sensorimotor outcomes.

Control group: Participants take part in a non-music control intervention which relies on existing behavioural interventions with no music. It is conducted in the same setting and by the same therapist as the musical intervention and will target similar outcomes, but without the use of any musical activities. Sessions involve play activities targeting social interaction, communication, emotional regulation and sensorimotor integration but without the use of any musical instruments. Toys, books, and other non-musical accessories will be used to engage the child.

All sessions (music and control sessions) will be video recorded for post-hoc analysis. Participants in both groups are followed up at the end of the intervention period (12 weeks) at which time they undergo an MRI scan.

Intervention type



Drug names

Primary outcome measure

1. Socio-communicative responsiveness (in the domains of Social Awareness, Social Cognition, Social Communication, Social Motivation, Restricted Interests and Repetitive Behavior) is measured using the Social Responsiveness Scale-2 at baseline and 12 weeks
2. Pragmatic language and communication skills are measured using the Children's Communication Checklist-2 at baseline and 12 weeks
3. Receptive vocabulary is measured using the Peabody Picture Vocabulary Test at baseline and 12 weeks
4. Functional brain connectivity was measured using resting-state functional MRI at baseline and at 12 weeks

Secondary outcome measures

1. Family quality of life is measured using the Beach Family Quality of Life Scale at baseline and at 12 weeks
2. Gross and fine-motor skills are measured using the Motor skills subdomain of the Vineland Adaptive Behaviour Scales (II) at baseline and at 12 weeks
3. Inhibitory control is measured by the Flanker and Go-No Go task at baseline and at 12 weeks
4. Musical abilities are measured by the Montreal Battery of Evaluation of Musical Abilities at baseline and at 12 weeks

Overall trial start date


Overall trial end date


Reason abandoned (if study stopped)


Participant inclusion criteria

1. Children aged 6-12 years
2. Diagnosis of Autism Spectrum Disorder
3. No co-morbid neurological disorder
4. No hearing impairment
5. No experience of music therapy in the 6 months preceding the start of the study

Participant type


Age group




Target number of participants

50 participants, with n=25 in each arm.

Participant exclusion criteria

1. Co-morbid neurological condition
2. Metallic implant in body
3. Hearing impairment
4. Experience of music therapy in the 6 months preceding the start of the study

Recruitment start date


Recruitment end date



Countries of recruitment


Trial participating centre

University of Montreal
International Laboratory of Brain Music and Sound (BRAMS) 1430 Mont-Royal Boulevard
H2V 4P3

Trial participating centre

McGill University
School of Communication Sciences and Disorders 845 Rue Sherbrooke Ouest
H3A 1G1

Trial participating centre

Westmount Music Therapy
4695 Maisonneuve Boulevard West
H3Z 1L9

Trial participating centre

Montreal Neurological Institute
3801 Rue University
H3A 2B4

Sponsor information


University of Montreal

Sponsor details

International Laboratory for Brain
Music and Sound Research (BRAMS)
1430 Mont-Royal Boulevard
H2V 2J2
+1 514 343 6111

Sponsor type




Funder type


Funder name

Quebec Bioimaging Network

Alternative name(s)

Funding Body Type

Funding Body Subtype


Results and Publications

Publication and dissemination plan

1. Publication of research findings in peer-reviewed open access journals
2. Presentation of findings at international and local scientific conferences
3. Permitted versions of articles will be made readily available on lab websites and through university repositories
4. Through local autism community organizations, parent workshops will be held to increase awareness about music-related services and the efficacy of these services for children with difficulties

Intention to publish date


Participant level data

Available on request

Basic results (scientific)

Publication list

1. 2018 results in:

Publication citations

Additional files

Editorial Notes

29/10/2018: Publication reference added. 05/03/2018: The intention to publish date has been changed from 01/09/2017 to 01/07/2018.